A CERN spin-off based in Geneva, Terapet develops PET-type technologies to verify in vivo the dose delivered in proton therapy. Under the Eurostars TheraVivo project, it has received EUR 772,000 in funding.
- Announced on
- Round
- Grant
- Amount
- EUR 772,000
- Location
- Geneva
- Sector
- Health & medtech
Investors
- Eurostars lead
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic